Position in LLY
as of Mar 31, 2026
· filed Jun 18, 2026
Position Value
$36,470,720
-$30,163,744 QoQ
Shares Held
39,652
-36.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Pacer Advisors, Inc. holds $1,682,910,775 across 10 Drug Manufacturers - General names. LLY ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
7,928,098 | $480,839,143 | |
| 2 | PFE |
Pfizer Inc
|
16,256,214 | $456,474,489 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,945,242 | $410,478,377 | |
| 4 | BIIB |
Biogen Inc.
|
660,408 | $121,072,598 | |
| 5 | MRK |
Merck & Co., Inc.
|
732,981 | $88,170,284 | |
| 6 | ABBV |
AbbVie Inc.
|
192,847 | $41,942,294 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
39,652 | $36,470,720 | |
| 8 | JNJ |
Johnson & Johnson
|
127,383 | $31,137,500 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,470,720 | 39,652 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $66,634,464 | 62,004 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $48,722,891 | 63,857 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $49,550,044 | 63,564 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,240,399 | 40,247 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $48,429,876 | 62,733 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $52,092,386 | 58,799 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $61,581,231 | 68,017 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $50,025,939 | 64,304 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $45,529,549 | 78,106 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $35,021,950 | 65,202 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $29,017,199 | 61,873 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $20,247,699 | 58,959 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,017,766 | 2,782 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,129,461 | 3,493 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $1,046,938 | 3,229 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,693,346 | 40,833 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $14,167,047 | 51,289 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $11,288,871 | 48,859 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $10,742,683 | 46,805 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $8,149,275 | 43,621 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $8,325,500 | 49,310 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $8,924,717 | 60,294 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $12,225,171 | 74,462 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||